UK equities are having their time in the sun. The FTSE 100 recently hit an all-time high of 9,000, driven by a broad recovery in equity prices. To put it another way, the rally wasn’t just driven by a

Companies in the news and how they were assessed

Investors should consider shifting their focus to ‘old economy’ stocks rather than technology

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

CITY

Who’s tipping what The week’s best shares ...